标题
Safety of biologic therapy in rheumatoid arthritis
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 7, Issue 11, Pages 639-652
出版商
Springer Nature
发表日期
2011-10-11
DOI
10.1038/nrrheum.2011.145
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
- (2012) Teresa A Simon et al. ARTHRITIS RESEARCH & THERAPY
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
- (2011) K. Au et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
- (2011) Deborah P. M. Symmons et al. Nature Reviews Rheumatology
- Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
- (2011) Wassila Amari et al. RHEUMATOLOGY
- Adverse Cutaneous Reactions Induced by TNF-α Antagonist Therapy
- (2011) Joaquín Borrás-Blasco et al. SOUTHERN MEDICAL JOURNAL
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
- (2010) A. M. Evens et al. ANNALS OF ONCOLOGY
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Pregnancy outcomes after maternal exposure to rituximab
- (2010) E. F. Chakravarty et al. BLOOD
- Safety profile of abatacept in rheumatoid arthritis: A review
- (2010) Majed Khraishi et al. CLINICAL THERAPEUTICS
- The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
- (2010) Joost Frans Swart et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical safety of tocilizumab in rheumatoid arthritis
- (2010) Bernard Bannwarth et al. Expert Opinion On Drug Safety
- A safety assessment of tumor necrosis factor antagonists during pregnancy
- (2010) Vanessa C Osting et al. Expert Opinion On Drug Safety
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2010) Norihiro Nishimoto et al. Modern Rheumatology
- Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis
- (2010) Sing Your Li et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
- (2010) J. B. Galloway et al. RHEUMATOLOGY
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity
- (2009) S. Salemi et al. CLINICAL IMMUNOLOGY
- Dermatological complications and safety of anti-TNF treatments
- (2009) J. F. Kerbleski et al. GUT
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
- (2009) Ann Corken Mackey et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor- Blocker in the Treatment of Rheumatic Diseases
- (2009) Y. J. KIM et al. JOURNAL OF RHEUMATOLOGY
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
- (2009) J. D. CARTER et al. JOURNAL OF RHEUMATOLOGY
- Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
- (2009) R. WESTHOVENS et al. JOURNAL OF RHEUMATOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy?
- (2009) Y. M. ALI et al. JOURNAL OF RHEUMATOLOGY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
- (2008) T A Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
- (2008) M Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
- (2008) J Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
- (2008) N Nishimoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
- (2008) J Askling et al. ANNALS OF THE RHEUMATIC DISEASES
- Immediate Type I Hypersensitivity Response Implicated in Worsening Injection Site Reactions to Adalimumab
- (2008) Michael Paltiel et al. ARCHIVES OF DERMATOLOGY
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) Jonathan Kay et al. ARTHRITIS AND RHEUMATISM
- Inflammatory demyelinating events following treatment with anti-tumor necrosis factor
- (2008) A. Fromont et al. CYTOKINE
- Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study
- (2008) AC Davaine et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy
- (2008) Shunsuke Mori et al. Modern Rheumatology
- Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis
- (2008) L. L. Teichmann et al. RHEUMATOLOGY
- Use of Tumor Necrosis Factor-α Inhibitors in Patients with Chronic Hepatitis B Infection
- (2008) Matthew B. Carroll et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation